Dynamk Capital LLC

10/30/2024 | Press release | Archived content

Virica Biotech is Building an Ecosystem to Ramp Up AAV Production

Portfolio company Virica Biotech made two recent collaboration announcements highlighting the industry embracing their cell enhancing platform for improving adeno-associated vectors (AAVs) production. Virica and eXmoor Pharma announced a new collaboration project funded by a joint UK-Canada government initiative. This project aims to enhance the manufacturing of AAVs crucial for gene therapies, ultimately reducing costs and improving the accessibility of life-saving therapies.

Dynamk Capital LLC published this content on October 30, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 06, 2026 at 12:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]